Literature DB >> 15988621

Ipsilateral breast tumor recurrence after breast-conserving therapy: A comparison of quadrantectomy versus lumpectomy at a single institution.

Woo Chul Noh1, Nam Sun Paik, Min Suk Kim, Kwang Mo Yang, Chul Koo Cho, Dong Wook Choi, Jong Inn Lee, Sung Ku Kang, Sang Bum Kim, Nan Mo Moon.   

Abstract

The aims of study were to compare the rates of ipsilateral breast tumor recurrence (IBTR), for patients treated with either quadrantectomy or lumpectomy at a single institution, and to identify predictors of IBTR after breast-conserving therapy (BCT). The database and medical records of 807 patients who underwent BCT for breast cancer between 1987 and 2002 were reviewed. The age of the patient, tumor size, lymph node status, extensive intraductal component (EIC), re-excision, final margin status, and the extent of surgery were examined in reference to IBTR rates. Of the total 807 patients, 456 (56.5%) had undergone quadrantectomy and 351 patients (43.5%) had lumpectomy. Apart from the higher re-excision rate in the lumpectomy group (p < 0.001), there were no significant differences in clinical and pathologic characteristics between the patients in the two groups. At the median follow-up time of 72 months, 28 cases of IBTR (3.4%) and 56 cases of systemic recurrence (6.9%) had developed in 72 patients (8.9%). On multivariate analysis, young age (< or =35) (p = 0.041), positive lymph node (p < 0.001), and the presence of EIC (p = 0.004) were independent predictors of IBTR. However, we could not find a significant difference in IBTR rate between the two groups (p = 0.546). Thus, the extent of breast surgery (quadrantectomy or lumpectomy) did not make a significant difference in IBTR if adequate surgical margins could be achieved.

Entities:  

Mesh:

Year:  2005        PMID: 15988621     DOI: 10.1007/s00268-005-7928-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer.

Authors:  L J Solin; B L Fowble; D J Schultz; R L Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

2.  Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.

Authors:  Nadeem Q Mirza; Georges Vlastos; Funda Meric; Thomas A Buchholz; Nestor Esnaola; S Eva Singletary; Henry M Kuerer; Lisa A Newman; Frederick C Ames; Merrick I Ross; Barry W Feig; Raphael E Pollock; Marsha McNeese; Eric Strom; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2002-04       Impact factor: 5.344

3.  True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.

Authors:  T E Smith; D Lee; B C Turner; D Carter; B G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

4.  Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.

Authors:  H P Sinn; H W Anton; A Magener; D von Fournier; G Bastert; H F Otto
Journal:  Eur J Cancer       Date:  1998-04       Impact factor: 9.162

5.  Risk factors for local recurrence after breast-conserving surgery.

Authors:  I Fredriksson; G Liljegren; M Palm-Sjövall; L-G Arnesson; S O Emdin; T Fornander; A Lindgren; H Nordgren; I Idvall; M Holmqvist; L Holmberg; J Frisell
Journal:  Br J Surg       Date:  2003-09       Impact factor: 6.939

6.  Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

Authors:  B Fisher; J Dignam; E P Mamounas; J P Costantino; D L Wickerham; C Redmond; N Wolmark; N V Dimitrov; D M Bowman; A G Glass; J N Atkins; N Abramson; C M Sutherland; B S Aron; R G Margolese
Journal:  J Clin Oncol       Date:  1996-07       Impact factor: 44.544

7.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

8.  Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.

Authors:  Funda Meric; Nadeem Q Mirza; Georges Vlastos; Thomas A Buchholz; Henry M Kuerer; Gildy V Babiera; S Eva Singletary; Merrick I Ross; Frederick C Ames; Barry W Feig; Savitri Krishnamurthy; George H Perkins; Marsha D McNeese; Eric A Strom; Vicente Valero; Kelly K Hunt
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

9.  Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?

Authors:  Frank A Vicini; Larry Kestin; Raywin Huang; Alvaro Martinez
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

10.  Is the reexcision rate higher if breast conservation surgery is performed by surgical trainees?

Authors:  Krishna Moorthy; Vipin Asopa; Elizabeth Wiggins; Michael Callam
Journal:  Am J Surg       Date:  2004-07       Impact factor: 2.565

View more
  4 in total

1.  Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer.

Authors:  Peter J Lovrics; Sylvie D Cornacchi; Forough Farrokhyar; Anna Garnett; Vicky Chen; Slobodan Franic; Marko Simunovic
Journal:  Can J Surg       Date:  2010-10       Impact factor: 2.089

2.  Safe negative margin width in breast conservative therapy: results from a population with a high percentage of negative prognostic factors.

Authors:  Abu Bakar Bhatti; Amina Khan; Narjis Muzaffar; Neelam Siddiqui; Aamir Syed; Mazhar Shah; Awais Aamir; Arif Jamshed
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

3.  Results of breast conserving surgery in clinical stage I-II breast carcinoma.

Authors:  Erhan Erdem; Haluk Alagol
Journal:  Indian J Surg       Date:  2009-03-13       Impact factor: 0.656

Review 4.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.